1. Others Immunology/Inflammation PI3K/Akt/mTOR Apoptosis MAPK/ERK Pathway Metabolic Enzyme/Protease NF-κB
  2. Akt p38 MAPK Reactive Oxygen Species (ROS) Environmental Pollutants Endogenous Metabolite Apoptosis
  3. Bisphenol A

Bisphenol A is a phenolic, organic synthetic compound widely used in the production of polycarbonate plastics and epoxy resins. Bisphenol A is a reproductive, developmental, and systemic toxicant, often classified as an endocrine-disrupting compound (EDC). Bisphenol A is associated with many diseases, including cancers, cardiovascular diseases, respiratory diseases, diabetes, kidney diseases, obesity, and reproductivedisorders.

For research use only. We do not sell to patients.

CAS No. : 80-05-7

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
100 mg In-stock
500 mg In-stock
1 g In-stock
5 g In-stock
10 g In-stock
25 g In-stock
50 g In-stock
100 g In-stock
> 100 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 14 publication(s) in Google Scholar

Other Forms of Bisphenol A:

Top Publications Citing Use of Products

    Bisphenol A purchased from MedChemExpress. Usage Cited in: Environ Sci Technol. 2025 Oct 28;59(42):22423-22438.  [Abstract]

    Bisphenol A (BPA) (20-2000 μg/kg; i.g.; once daily for 4 weeks) significantly downregulated GPX4 expression in the testes of mice in a dose-dependent manner.

    Bisphenol A purchased from MedChemExpress. Usage Cited in: Environ Sci Technol. 2025 Oct 28;59(42):22423-22438.  [Abstract]

    Bisphenol A (BPA) (20-2000 μg/kg; i.g.; once daily for 4 weeks) induced testicular atrophy and significantly decreased the index of the mice testis.

    Bisphenol A purchased from MedChemExpress. Usage Cited in: Environ Sci Technol. 2025 Oct 28;59(42):22423-22438.  [Abstract]

    Bisphenol A (BPA) (20-2000 μg/kg; i.g.; once daily for 4 weeks) increased iron and malondialdehyde (MDA) content while significantly decreased the GSH/GSSG ratio in mice testis.

    Bisphenol A purchased from MedChemExpress. Usage Cited in: Environ Sci Technol. 2025 Oct 28;59(42):22423-22438.  [Abstract]

    Histological changes and TEM imaging images of mitochondria structures in the testes of Bisphenol A (BPA) (20-2000 μg/kg; i.g.; once daily for 4 weeks)-treated mice. NST, normal seminiferous tubule; DST, damaged seminiferous tubule; LC, Leydig cells; Sg, spermatogonia. M, mitochondria; LC, loss of mitochondrial cristae; rOM, ruptured mitochondrial outer membrane; AL, autolysosome; SM, shrunken mitochondria.

    Bisphenol A purchased from MedChemExpress. Usage Cited in: Environ Sci Technol. 2025 Oct 28;59(42):22423-22438.  [Abstract]

    Bisphenol A (BPA) (20-2000 μg/kg; i.g.; once daily for 4 weeks) significantly upregulated the protein expression of both estrogen receptors ERα and ERβ, as well as the G protein-coupled estrogen receptor (GPER) in mice testes, in a dose-dependent manner.

    View All Akt Isoform Specific Products:

    View All p38 MAPK Isoform Specific Products:

    View All Endogenous Metabolite Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Bisphenol A is a phenolic, organic synthetic compound widely used in the production of polycarbonate plastics and epoxy resins. Bisphenol A is a reproductive, developmental, and systemic toxicant, often classified as an endocrine-disrupting compound (EDC). Bisphenol A is associated with many diseases, including cancers, cardiovascular diseases, respiratory diseases, diabetes, kidney diseases, obesity, and reproductivedisorders[1][2][3][4][5][6][7][8][9].

    Cellular Effect
    Cell Line Type Value Description References
    B16 IC50
    0.0086 M
    Compound: BAP
    Compound was tested for the in vitro growth inhibition of B-16 melanoma cells after incubation for 3 days (cytotoxicity), the dose that failed to inhibit cell growth by more than 50% was determined
    Compound was tested for the in vitro growth inhibition of B-16 melanoma cells after incubation for 3 days (cytotoxicity), the dose that failed to inhibit cell growth by more than 50% was determined
    [PMID: 9288164]
    HEK293 EC50
    1689 nM
    Compound: 3; BPA
    Selective estrogen receptor down-regulator activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ERalpha degradation by luciferase reporter gene assay
    Selective estrogen receptor down-regulator activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ERalpha degradation by luciferase reporter gene assay
    [PMID: 30940565]
    HEK293 EC50
    > 10000 nM
    Compound: 3; BPA
    Agonist activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ER-alpha-mediated transcriptional activity by luciferase reporter gene assay
    Agonist activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ER-alpha-mediated transcriptional activity by luciferase reporter gene assay
    [PMID: 30940565]
    HEK293 IC50
    > 10000 nM
    Compound: 3; BPA
    Antagonist activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as reduction in E2-induced ER-alpha-mediated transcriptional activity by luciferase reporter gene assay
    Antagonist activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as reduction in E2-induced ER-alpha-mediated transcriptional activity by luciferase reporter gene assay
    [PMID: 30940565]
    HT-22 IC50
    97 μM
    Compound: 33
    Cytotoxicity against mouse HT-22 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
    Cytotoxicity against mouse HT-22 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
    [PMID: 36876904]
    HeLa EC50
    757 nM
    Compound: BPA
    Agonist activity at ERbeta (unknown origin) expressed in human HeLa cells assessed as transcriptional activation measured after 24 hrs by luciferase reporter gene assay
    Agonist activity at ERbeta (unknown origin) expressed in human HeLa cells assessed as transcriptional activation measured after 24 hrs by luciferase reporter gene assay
    [PMID: 31879182]
    HeLa EC50
    797 nM
    Compound: BPA
    Agonist activity at ERalpha (unknown origin) expressed in human HeLa cells assessed as transcriptional activation measured after 24 hrs by luciferase reporter gene assay
    Agonist activity at ERalpha (unknown origin) expressed in human HeLa cells assessed as transcriptional activation measured after 24 hrs by luciferase reporter gene assay
    [PMID: 31879182]
    MCF7 EC50
    0.29 μM
    Compound: 4; BPA
    Agonist activity at estrogen receptor in human MCF7 cells assessed as ERE-mediated transcriptional activity after 24 hrs by luciferase assay
    Agonist activity at estrogen receptor in human MCF7 cells assessed as ERE-mediated transcriptional activity after 24 hrs by luciferase assay
    [PMID: 26905830]
    In Vitro

    Bisphenol A significantly reduces the viability, increases and decreases levels of intracellular ROS production and antioxidant capacity, respectively, in KGN cells[1].
    Bisphenol A (100 fM-100 μM, 24-72 h) decreases granulosa cell viability and induces apoptosis and G2-to-M arrest of ovarian granulosa cells[3].
    Bisphenol A (0-400 μM, 24 h) suppresses proliferation and induces apoptosis in human colon cancer cells HCT116 through mitochondrial and MAPK/AKT pathways[4].
    Bisphenol A (0.5-12.5 μM, 5 days) significantly inhibits RANKL-induced, TRAP-positive multinucleated cell formation in bone marrow-derived macrophages and RAW 264.7 cell cultures[5].
    Bisphenol A (0.5-12.5 μM) suppresses ALP activities and bone nodule formation in MC3T3-E1 cells[5].
    Bisphenol A (0.06-500 μM, 1 h) induces morphological and biochemical alterations in human peripheral blood mononuclear cells[6].
    Bisphenol A (0.0020-2.0 μM, 24-48 h) decreases viability and induces dysfunction of insulin secretion and apoptosis through the damage of mitochondria in rat insulinoma (INS-1) cells[7].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Viability Assay[5]

    Cell Line: RAW264.7 cells
    Concentration: 0.5, 2.5, 12.5 μM
    Incubation Time: 24 h
    Result: Significantly reduced to 80% at 12.5 μM.

    Apoptosis Analysis[5]

    Cell Line: RAW264.7 cells
    Concentration: 0.5, 2.5, 12.5 μM
    Incubation Time: 24 h
    Result: Stimulated apoptosis in a dose-dependent manner in both cells.
    Up-regulated Bax and down-regulated Bcl2 in both cells.
    In Vivo

    Bisphenol A (200 mg/kg/day, s.c., 4 weeks) significantly decreases testis, epididymis, prostate and seminal vesicle weights, and the testicular daily sperm production in Jcl:Wistar rats[8].
    Bisphenol A (500-1250 mg/kg/day, gastric intubation, gestational days 6 through 15) induces maternal mortality and fetal toxicity in CD-1 mice[9].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Molecular Weight

    228.29

    Formula

    C15H16O2

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    CC(C1=CC=C(O)C=C1)(C2=CC=C(O)C=C2)C

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    Store at room temperature 3 years

    In solvent -80°C 2 years
    -20°C 1 year
    Solvent & Solubility
    In Vitro: 

    DMSO : 100 mg/mL (438.04 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    H2O : < 0.1 mg/mL (insoluble)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 4.3804 mL 21.9020 mL 43.8039 mL
    5 mM 0.8761 mL 4.3804 mL 8.7608 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.08 mg/mL (9.11 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.08 mg/mL (9.11 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.91%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 4.3804 mL 21.9020 mL 43.8039 mL 109.5098 mL
    5 mM 0.8761 mL 4.3804 mL 8.7608 mL 21.9020 mL
    10 mM 0.4380 mL 2.1902 mL 4.3804 mL 10.9510 mL
    15 mM 0.2920 mL 1.4601 mL 2.9203 mL 7.3007 mL
    20 mM 0.2190 mL 1.0951 mL 2.1902 mL 5.4755 mL
    25 mM 0.1752 mL 0.8761 mL 1.7522 mL 4.3804 mL
    30 mM 0.1460 mL 0.7301 mL 1.4601 mL 3.6503 mL
    40 mM 0.1095 mL 0.5475 mL 1.0951 mL 2.7377 mL
    50 mM 0.0876 mL 0.4380 mL 0.8761 mL 2.1902 mL
    60 mM 0.0730 mL 0.3650 mL 0.7301 mL 1.8252 mL
    80 mM 0.0548 mL 0.2738 mL 0.5475 mL 1.3689 mL
    100 mM 0.0438 mL 0.2190 mL 0.4380 mL 1.0951 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Bisphenol A
    Cat. No.:
    HY-18260
    Quantity:
    MCE Japan Authorized Agent: